Dissection of the Molecular and Immunological Interaction in Patients With HCC of Viral and Non-viral Etiologies

NCT05613621 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 579

Last updated 2025-08-15

No results posted yet for this study

Summary

This project will clarify the potential interaction between HBV infection and steatosis, and their impact on genetic alterations and tumor immune microenvironment.

Conditions

Sponsors & Collaborators

  • National Taiwan University Hospital

    collaborator OTHER
  • Mackay Memorial Hospital

    collaborator OTHER
  • National Cheng-Kung University Hospital

    collaborator OTHER
  • National Health Research Institutes, Taiwan

    lead OTHER

Principal Investigators

  • Tsang-Wu Liu · Taiwan Cooperative Oncology Group, NHRI

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-14
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05613621 on ClinicalTrials.gov